Диссертация (1139842), страница 21
Текст из файла (страница 21)
– Т. 74. – №. 2. – С. 301-306.157.McCarthy R. C., Kosman D. J. Glial cell ceruloplasmin and hepcidindifferentially regulate iron efflux from brain microvascular endothelial cells// PLoS One. – 2014. – Т. 9. – №. 2. – С. e89003.158.McDonagh T., Macdougall I. C.
Iron therapy for the treatment of irondeficiency in chronic heart failure: intravenous or oral? // European journalof heart failure. – 2015. – Т. 17. – №. 3. – С. 248-262.159.Means J. R. T. Recent developments in the anemia of chronic disease// Current hematology reports. – 2003. – Т. 2.
– №. 2. – С. 116-121.160.Merle U., Fein E., Gehrke S. G.et al. The iron regulatory peptidehepcidin is expressed in the heart and regulated by hypoxia andinflammation // Endocrinology. – 2007. – Т. 148. – №. 6. – С. 2663-2668.161.Mizuno M., Kajimoto, K., Sato, N.et al. Clinical profile, management,and mortality in very-elderly patients hospitalized with acute decompensatedheart failure: An analysis from the ATTEND registry // European journal ofinternal medicine. – 2016.
– Т. 27. – С. 80-85.162.Mozaffarian D., Nye R., Levy W. C. Anemia predicts mortality insevere heart failure: the prospective randomized amlodipine survivalevaluation (PRAISE) // Journal of the American College of Cardiology. –2003. – Т. 41. – №. 11. – С. 1933-1939.163.Munoz M., García-Erce J.
A., Remacha Á. F. Disorders of ironmetabolism. Part II: iron deficiency and iron overload // Journal of clinicalpathology. – 2011. – Т. 64. – №. 4. – С. 287-296.164.Muzzarelli S., Pfisterer M. Anemia as independent predictor of majorevents in elderly patients with chronic angina //American heart journal. –2006. – Т.
152. – №. 5. – С. 991-996.165.Nagai T., Nishimura, K., Honma, T.et al. Prognostic significance ofendogenous erythropoietin in long‐term outco120decompensated heart failure // European journal of heart failure. – 2016. – Т.18. – №. 7. – С. 803-813.166.Nairz M., Theurl, I., Wolf, D. et al. Iron deficiency or anemia ofinflammation? // Wiener Medizinische Wochenschrift. – 2016. – Т. 166. –№.
13-14. – С. 411-423.167.Naito Y, Hosokawa, M., Sawada, H. et al. Hepcidin is increased in thehypertrophied heart of Dahl salt-sensitive rats // International journal ofcardiology. – 2014. – Т. 172. – №. 1. – С. 45-47.168.Nakano H., Nagai, T., Sundaram, V. et al. Impact of iron deficiencyon long-term clinical outcomes of hospitalized patients with heart failure //International journal of cardiology.
– 2018. – Т. 261. – С. 114-118.169.Nanas J, Matsouka C, Karageorgopoulos D. et al. Etiology of anemiain patients with advanced heart failure // Journal of the American College ofCardiology. – 2006. – Т. 48. – №. 12. – С. 2485-2489.170.Nemeth Е, Tuttle М, PoweisonJ et al. Hepcidin regulates cellular ironefflux by binding to ferroportin and inducing its internalization // Science. –2004. – Т. 306. – №. 5704. – С. 2090-2093.171.Nemeth E, Valore EV, Territo M. et al.
Hepcidin, a putative mediatorof anemia of inflammation, is a type II acute-phase protein // Blood. – 2003.– Т. 101. – №. 7. – С. 2461-2463.172.Nemeth E., Preza, G. C., Jung, C. L.et al. The N-terminus of hepcidinis essential for its interaction with ferroportin: structure-function study //Blood. – 2006. – Т. 107. – №. 1. – С. 328-333.173.Nemeth E., Rivera S., Gabajan V. et al. IL-6 mediates hypoferremia ofinflammation by inducing the synthesis of the iron regulatory hormonehepcidin // The Journal of clinical investigation.
– 2004. – Т. 113. – №. 9. –С. 1271-1276.174.Nicolas G., Bennoun M., Devaux L. et al. Lack of hepcidin geneexpression and severe tissue iron overload in upstream stimulatory factor 2121(USF2) knockout mice // Proceedings of the National Academy of Sciences.– 2001. – Т. 98. – №. 15. – С.
8780-8785.175.Nicolas G., Bennoun, M., Porteu, A.et al. Severe iron deficiencyanemia in transgenic mice expressing liver hepcidin // Proceedings of theNational Academy of Sciences. – 2002. – Т. 99. – №. 7. – С. 4596-4601.176.Nicolas G., Chauvet, C., Viatte, L.et al. The gene encoding the ironregulatory peptide hepcidin is regulated by anemia, hypoxia, andinflammation // The Journal of clinical investigation. – 2002. – Т. 110. – №.7. – С. 1037-1044.177.Nicolas G., Viatte, L., Bennoun, M.
et al. Hepcidin, a new ironregulatory peptide // Blood Cells, Molecules, and Diseases. – 2002. – Т. 29.– №. 3. – С. 327-335.178.Nieminen M. S., Brutsaert, D., Dickstein, K.et al. EuroHeart FailureSurvey II (EHFS II): a survey on hospitalized acute heart failure patients:description of population // European heart journal. – 2006.
– Т. 27. – №. 22.– С. 2725-2736.179.Nissenson A. R., Goodnough L. T., Dubois R. W. Anemia: not just aninnocent bystander? //Archives of internal medicine. – 2003. – Т. 163. – №.12. – С. 1400-1404.180.Niu J., Kolattukudy P. E. Role of MCP-1 in cardiovascular disease:molecular mechanisms and clinical implications // Clinical science. – 2009.– Т. 117. – №. 3. – С. 95-109.181.Okonko D.O., Grzeslo A., Witkowski T.
et al. Effect of intravenousiron sucrose on exercise tolerance in anemic and nonanemic patients withsymptomatic chronic heart failure and iron deficiency: FERRIC-HF: arandomized, controlled, observer-blinded trial // Journal of the AmericanCollege of Cardiology. – 2008. – Т. 51.
– №. 2. – С. 103-112.182.O'meara E., Rouleau, J. L., White, M. et al. Heart failure with anemia:novel findings on the roles of renal disease, interleukins, and specific left122ventricular remodeling processes // Circulation: Heart Failure. – 2014. – С.114.183.Opasich C., Cazzola, M., Scelsi, L.et al. Blunted erythropoietinproduction and defective iron supply for erythropoiesis as major causes ofanaemia in patients with chronic heart failure // European heart journal.
–2005. – Т. 26. – №. 21. – С. 2232-2237.184.Oren Н., Erbay A.R., Balci, M. et al. Role of novel biomarkers ofinflammation in patients with stable coronary heart disease //Angiology. –2007. – Т. 58. – №. 2. – С. 148-155.185.Oudejans I., Mosterd A., Bloemen J.A. et al. Clinical evaluation ofgeriatric outpatients with suspected heart failure: value of symptoms, signs,and additional tests // European journal of heart failure.
– 2011. – Т. 13. –№. 5. – С. 518-527.186.Pak M., Lopez M.A., Gabayan V. et al. Suppression of hepcidinduring anemia requires erythropoietic activity // Blood. – 2006. – Т. 108. –№. 12. – С. 3730-3735.187.Palazzuoli A, Gallotta M, Iovine F et al. Anaemia in heart failure: acommon interaction with renal insufficiency called the cardio‐renalanaemia syndrome // International journal of clinical practice. – 2008.
– Т.62. – №. 2. – С. 281-286.188.Palazzuoli A., Ruocco, G., Pellegrini, M.et al. The role oferythropoietin stimulating agents in anemic patients with heart failure:solved and unresolved questions // Therapeutics and Clinical RiskManagement. – 2014. – Т. 10. – С. 641.189.Park C. H., Valore, E. V., Waring, A. J et al. Hepcidin, a urinaryantimicrobial peptide synthesized in the liver // Journal of biologicalchemistry.
– 2001. – Т. 276. – №. 11. – С. 7806-7810.190.Pechlaner R., Kiechl, S., Mayr, M. et al. Correlates of serum hepcidinlevels and its association with cardiovascular disease in an elderly general123population // Clinical Chemistry and Laboratory Medicine (CCLM).
– 2016.– Т. 54. – №. 1. – С. 151-161.191.Perez A., Grodin, J., Hernandez, A.et al. Interleukin-6 is associatedwith, but does not independently predict, mortality in acute heart failure: anascend-hf substudy // journal of the american college of cardiology. – 2015.– Т. 65. – №. 10 supplement. – с. 1006.192.Pigeon C, Ilyin G, Courselaud B. et al.
et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobialpeptide hepcidin, is overexpressed during iron overload // Journal ofbiological chemistry. – 2001. – Т. 276. – №. 11. – С. 7811-7819.193.Ponikowski P. Voors A.A, Anker S.D.et al. ESC Guidelines for thediagnosis and treatment of acute and chronic heart failure: The Task Forcefor the diagnosis and treatment of acute and chronic heart failure of theEuropean Society of Cardiology (ESC) Developed with the specialcontribution of the Heart Failure Association (HFA) of the ESC // Europeanheart journal. – 2016.
– Т. 37. – №. 27. – С. 2129-2200.194.Ponikowski P., Voors, A. A., Anker, S. D. et al. Рекомендации ESCпо диагностике и лечению острой и хронической сердечнойнедостаточности 2016 // Российский кардиологический журнал. – 2017.– №. 1. – С. 7-81.195.Przybyszewska J., Żekanowska E. The role of hepcidin, ferroportin,HCP1, and DMT1 protein in iron absorption in the human digestive tract //Przeglad gastroenterologiczny. – 2014.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
